HMGCR and prostate cancer: Consequently, in tumors (e.g., prostate cancer, breast cancer), HMGCR overexpression establishes a dual Hippo-YAP/TAZ and Hedgehog pathway, while inhibiting p38 MAPK enhances cellular anti-apoptotic capacity.